Amy Conrad | Investor Relations |
Erik Holmlin | Chief Executive Officer |
Christopher Stewart | Chief Financial Officer |
Jeffrey Cohen | Ladenburg Thalmann |
Good day, and welcome to the Bionano Genomics Third Quarter 2022 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Amy Conrad from Investor Relations. Please go ahead, ma'am.
Thank you, Cynthia, and good afternoon, everyone.